Vial has a portfolio of wholly owned assets in Oncology, Ophthalmology, I&I, Cardiometabolic, and Rare Diseases - these assets are primarily Antibody (mAb, TCE, bsAb) and RNA treatments (siRNA, ASO).
Interested in licensing one of our assets? Leave us a message and some of your contact info and we’ll be in touch with you shortly.